MedPath

CHEMILL PHARMA LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

PPB:59

Drug Approvals

IVABRADINE TABLETS 5MG

Approval Date
Jun 11, 2025
PPB

IVABRADINE TABLETS 7.5MG

Approval Date
Jun 11, 2025
PPB

DARUNAVIR TABLETS 600MG

Approval Date
Apr 7, 2025
PPB

DECITABINE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG

Approval Date
Mar 31, 2025
PPB

SUNITINIB CAPSULES 12.5MG

Approval Date
Mar 26, 2025
PPB

SUNITINIB CAPSULES 50MG

Approval Date
Mar 26, 2025
PPB

IMATINIB TABLETS 100MG

Approval Date
Mar 11, 2025
PPB

SORAFENIB TABLETS USP 200MG

Approval Date
Mar 11, 2025
PPB

MILRINONE LACTATE INJECTION USP 10MG/10ML

Approval Date
Feb 24, 2025
PPB

ROFMILAS TABLETS 500MCG

Approval Date
Jan 8, 2025
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.